Feedback / Questions
Vynfinit (vintafolide) - Novartis
Company Presentation
(Endocyte)
-
Aug 10, 2012 -
"Met primary endpoint of clinical benefit & significant improvements in OS in FR (++) patients"
P2 data
•
Non Small Cell Lung Cancer
http://www.larvolonline.com/tlg/ccdb/EndocyteCompanyPresentationAug102012.pdf
Aug 10, 2012
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
(IR 7)